Human papillomavirus (HPV) types 16 and 18 in 66 women with histologically documented lesions of the genital tract and 64 control cohorts were investigated. The efficacies of in situ hybridization and polymerase chain reaction (PCR) in detecting HPV 16 and 18 DNA were analyzed. In order to assess the usefulness of replacing biopsies with cervical scrapes, the two samples were compared by PCR. The copy, and immunocytochemistry (6, 14, 36) . However, the viral antigens which can be detected immunocytochemically do not specify the HPV type. Nucleic acid hybridization techniques with radiolabeled or nonisotopic probes are the only methods available for typing HPVs present in infected tissues (5, 36). The presence of HPV DNA extracted from tissue samples can be determined by Southern blot or dot blot hybridization. These procedures, however, do not permit hybridization data and histology of the tissue to be correlated. In situ hybridization (ISH) is a less sensitive technique than Southern blot analysis, but it allows exact correlation between histology and individual viral genomes. The use of polymerase chain reaction (PCR), an in vitro DNA enzymatic amplification procedure (37), enhances the sensitivity of DNA hybridization probes and has contributed to an increase in the detection of HPV DNA in scrapes and biopsies from women with carcinomas and precancerous lesions of the cervix (29, 46) . Prevalence studies using different hybridization techniques to examine HPV-related lesions or normal Papanicolaou smears have provided conflicting results (13, 20, 29, 42, 51) . Interlaboratory variations due to the use of differing protocols or deviations in test performance as well as geographic differences in the distribution of the various HPV types may account for the varying prevalence rates of HPV genotypes (16, 24) .
Human papillomaviruses (HPVs) are members of the Papovaviridae family and contain circular double-stranded DNA approximately 8 kb in length (2) . The application of DNA hybridization techniques led to the characterization of distinct HPV types (15, 19) . More than 66 different genotypes have been identified (45) , and approximately 18 of them have been associated with neoplastic lesions of the anogenital mucosa and skin (26) . The association of particular types with genital cancer is now well documented (18, 54) . On this basis, HPVs have been categorized into low-risk (e.g., HPV 6 and 11) and high-risk (e.g., HPV 16, 18, 31, 33, and 35) virus types reflecting their oncogenic potential. HPV 6 and 11 frequently coexist with cervical condylomata and minor dysplasias (4), while HPV 16 and 18 have been found in high-grade premalignancies and invasive cancers (26, 41) .
Important differences in the physical states of HPV DNA have been demonstrated with benign and malignant lesions.
HPVs are maintained as extrachromosomal circular DNA episomes in benign cervical lesions, whereas the viral DNA appears to be integrated within the host genome in most cervical carcinomas (17) . The integration of HPV DNA sequences can be an early event in the progression of genital tumors, but this is not in itself sufficient to transform the cell (39) . Current data suggest that other initiating events, such as herpes simplex virus infections (53) , cigarette smoking (21) , and prolonged use of oral contraceptives (7) , could interact synergistically with HPVs in the development of malignancies of the genital tract (11) .
Growth of HPV in cell cultures has not yet been obtained. Methods of detection of HPV infection include colposcopic examination, cytomorphology-histology, electron micros-* Corresponding author. copy, and immunocytochemistry (6, 14, 36) . However, the viral antigens which can be detected immunocytochemically do not specify the HPV type. Nucleic acid hybridization techniques with radiolabeled or nonisotopic probes are the only methods available for typing HPVs present in infected tissues (5, 36) . The presence of HPV DNA extracted from tissue samples can be determined by Southern blot or dot blot hybridization. These procedures, however, do not permit hybridization data and histology of the tissue to be correlated. In situ hybridization (ISH) is a less sensitive technique than Southern blot analysis, but it allows exact correlation between histology and individual viral genomes. The use of polymerase chain reaction (PCR), an in vitro DNA enzymatic amplification procedure (37) , enhances the sensitivity of DNA hybridization probes and has contributed to an increase in the detection of HPV DNA in scrapes and biopsies from women with carcinomas and precancerous lesions of the cervix (29, 46) . Prevalence studies using different hybridization techniques to examine HPV-related lesions or normal Papanicolaou smears have provided conflicting results (13, 20, 29, 42, 51) . Interlaboratory variations due to the use of differing protocols or deviations in test performance as well as geographic differences in the distribution of the various HPV types may account for the varying prevalence rates of HPV genotypes (16, 24) .
The aims of this prospective study were (i) to compare the usefulness of ISH with that of PCR for detecting HPV Table 2 ). In the control cohort, the prevalence of HPV infection identified by PCR was 11% (7 of 64).
Electrophoresis on agarose gels and ethidium bromide staining were less sensitive than PCR and subsequent dot blot hybridization for the detection of HPV amplification products (Fig. 2) . Fourteen (25%) of the 55 biopsy cases which were positive by PCR and dot blot hybridization were positive by electrophoresis. With cervical scrapes, the corresponding figures were 5 of 10 (50%).
Altogether, HPV 16 and/or 18 DNA was detected by PCR with 39 (59%) of the 66 patients for whom both cervical biopsies and scrapes were analyzed (35 patients with PCRpositive biopsies and 4 patients for which PCR was only positive with cervical scrapes). In contrast, HPV 16 and/or 18 DNA was detected by ISH in 12 (18.1%) of the cases.
DISCUSSION
In the present study, HPV 16 DNA was detected by PCR in a significant proportion (35%) of chronic inflammation cases; all cases were negative by ISH. In a study carried out in China (43), HPV 16 DNA was detected by PCR in 20% of chronic cervicitis cases, 50% of dysplasias, and 60% of invasive carcinomas. The episomal form of HPV DNA was present in cervical benign lesions, whereas integration was associated with malignancy.
None of the 16 cases of condylomata was ISH positive. This finding agrees with the fact that condylomata are mainly related to replicative HPV 6 and 11 genotypes (36, 54) . However, 69 and 20% of the cases of condylomata were PCR positive with biopsy specimens and cervical scrapes, respectively. The coexistence of replicative HPV 6 and 11 with minimal amounts of HPV 16 and 18 may account for positive results by the PCR technique. The presence of HPV 16 DNA in condylomata has been previously reported (36) .
For cases of intraepithelial neoplasia, our detection rate of VOL. 31, 1993 on August 14, 2017 by guest http://jcm.asm.org/ Downloaded from 29% by ISH is similar to that reported in other studies in which biotinylated probes were used (10) . The frequency of HPV DNA detection is known to increase with the use of radiolabeled probes (38) . The detection rate with biopsies of intraepithelial neoplasias by PCR was 54%. The four cases of VIN were positive for HPV 16 DNA. These lesions are predominantly associated with HPV 16 infection (32) , as opposed to a more heterogeneous distribution of HPV DNA genotypes in cervical dysplasias (35) . Our rate of HPV 16 infection in cases of intraepithelial neoplasia (45.7%) is lower than those reported by others (20, 46) , which may be explained by geographic differences or interlaboratory variations in test performance, i.e., the use of a Southern blot to analyze the amplimers (16, 22, 23, 36) . In addition, recent evidence of HPV 16 DNA genomic diversity in the viral transcription region (25) may also account for the varying prevalence rates of HPV types. Mixed infections represented 5% of the biopsy specimens analyzed. In studies including multiple genotypes, the occurrence of mixed infections varied between 18 and 21% (29, 31) .
The detection rate for HPV 16 and/or 18 DNA infections decreased with the severity of the dysplastic lesion when ISH was used. In contrast, the detection rate for HPV 16 and/or 18 DNA increased with the severity of the lesion when biopsy specimens were analyzed by PCR. These HPV types have been associated with the progression of severe dysplasia to malignancy (9, 26) . CIN I has been associated with several HPV genotypes, and when HPV 16 or 18 is present, it is mainly in a replicative form (18) . However, high-grade dysplasias and carcinomas in situ are associated with a few viral types which are usually integrated within the host DNA (1, 17, 39); thus, PCR, which detects 1 DNA copy per 106 cells in 30 amplification cycles, is much more sensitive with severe dysplasias than ISH, which detects 5 to 800 copies per cell (3, 30, 38) . The greatest differences in the detection rates were found with CIN III (ISH, 0%; PCR, 63%). Note that in four cases (3 CIN I and 1 CIN II), HPV 16 and 18 DNA was only detected by ISH. Sampling errors (23) or variations in the genomic sequence complementary to the oligonucleotide used may explain this discrepancy. This finding has also been reported when Southern blot was compared with PCR (30) . The singular advantage of ISH is its ability to determine the location of the target DNA in the tissue sample.
The detection rates of HPV 16 DNA in patients with CIN are greater than those found with women with no evidence of histologic abnormalities, although a high prevalence of HPV 16 has also been detected in benign lesions of the cervix. Different physical states of HPV (26) . The integration of viral DNA in premalignant lesions results in the disruption of the E2 gene, which controls intraviral transcription. This implicates a disregulated expression of the viral oncoproteins. However, this fact has been revealed to be not enough for malignant transformation (39) . Other cellular events, such as the level of expression of c-myc oncogenes when viral DNA is integrated in the vicinity (43) or the role of tumor suppressor genes found in chromosome 11 (55) Cervical scrapes are less representative than biopsies, probably because of their smaller cellular content and the fact that biopsies are colposcopically directed. These findings suggest that cervical scrapes do not constitute the most suitable sample for screening HPV infection, although with 6% of our patients the infection was detected only by scraping. Zhang et al. (52) have pointed out that both methods are complementary. Differences in sampling efficiency may be reduced by standardizing the amount of nucleic acid analyzed. In order to obtain valid results with cervical scrapes, a minimum number of 105 to 106 epithelial cells would be necessary (28, 33, 52) .
The prevalence of HPV 16 DNA in cytologically normal smears varies between 2 and 84% (23, 29, 34, 44, 47, 49, 51) . Using the PCR technique, we could detect HPV 16 associated with normal cytology in 11% of the controls.
In conclusion, PCR is a sensitive method for detecting HPV infection. It is not as expeditious as expected, because of the need to increase the sensitivity by dot blot, which at the same time confirms the specificity of the amplimers shown by electrophoresis on agarose gels (34, 49, 51) . Biopsy specimens have been proven more suitable than cervical scrapes for HPV DNA detection, although a noninvasive sampling method such as cervicovaginal lavage also could be convenient. Conditions for the PCR technique, particularly the primers and the number of cycles, should be standardized in order to compare results from different laboratories and to draw conclusions about the role of HPV infection in genital carcinogenesis.
